Indirect comparison of efficacy of dupilumab versus mepolizumab and omalizumab for severe type 2 asthma

• Katrine Prætorius,
• Daniel P. Henriksen,
• Johannes M. Schmid,
• Pernille Printzlau,
• Lars Pedersen,
• Hanne Madsen,
• Ehm A. Andersson,
• Louise Klokker Madsen,
• Bo L. Chawes

Affiliations

Katrine Prætorius

Dept of Pediatric and Adolescent Medicine, Herlev and Gentofte Hospital, Copenhagen, Denmark

Daniel P. Henriksen

Dept of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark

Johannes M. Schmid

Dept of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark

Pernille Printzlau

The Capital Region Pharmacy, North Zealand Hospital, Hillerød, Denmark

Lars Pedersen

Dept of Respiratory Medicine, Bispebjerg Hospital, Copenhagen, Denmark

Hanne Madsen

Dept of Respiratory Medicine, Odense University Hospital, Odense, Denmark

Ehm A. Andersson

The Danish Medicines Council Secretariat, Copenhagen, Denmark

Louise Klokker Madsen

The Danish Medicines Council Secretariat, Copenhagen, Denmark

Bo L. Chawes

Dept of Pediatric and Adolescent Medicine, Herlev and Gentofte Hospital, Copenhagen, Denmark